Glutamate Receptor Antagonists Protect from Virus-induced Neural Degeneration

Jennifer L. Nargi-Aizenman, Michael B. Havert, Ming Zhang, David N. Irani, Jeffrey D. Rothstein, Diane E. Griffin

Research output: Contribution to journalArticle

Abstract

Neuronal damage during acute viral encephalomyelitis can result directly from virus infection or indirectly from the host immune response to infection. In neurodegenerative diseases and stroke, neuronal death also can result from excess release of excitatory amino acid neurotransmitters, such as glutamate. To determine the role of glutamate excitotoxicity in fatal alphavirus-induced paralytic encephalomyelitis, we treated mice infected with neuroadapted Sindbis virus (NSV) with antagonists of N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) subtypes of glutamate receptors. Both apoptotic and necrotic neurons in the hippocampus were decreased in animals treated with MK-801, an NMDA receptor antagonist, or GYKI-52466, an AMPA receptor antagonist. However, only AMPA receptor blockade prevented damage to spinal cord motor neurons and protected mice from paralysis and death due to NSV infection. Protection was not caused by altered virus replication because treatment did not affect virus distribution and actually delayed virus clearance. These results provide evidence that NSV infection activates neurotoxic pathways that result in aberrant glutamate receptor stimulation and neuronal damage. Furthermore, AMPA receptor-mediated motor neuron death is an important contributor to paralysis and mortality in acute alphavirus-induced encephalomyelitis.

Original languageEnglish (US)
Pages (from-to)541-549
Number of pages9
JournalAnnals of Neurology
Volume55
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Sindbis Virus
Encephalomyelitis
Excitatory Amino Acid Antagonists
AMPA Receptors
Virus Diseases
Alphavirus
Glutamate Receptors
Motor Neurons
Viruses
Paralysis
Glutamic Acid
Isoxazoles
Excitatory Amino Acids
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
Dizocilpine Maleate
N-Methylaspartate
Virus Replication
N-Methyl-D-Aspartate Receptors
Neurodegenerative Diseases
Neurotransmitter Agents

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Glutamate Receptor Antagonists Protect from Virus-induced Neural Degeneration. / Nargi-Aizenman, Jennifer L.; Havert, Michael B.; Zhang, Ming; Irani, David N.; Rothstein, Jeffrey D.; Griffin, Diane E.

In: Annals of Neurology, Vol. 55, No. 4, 04.2004, p. 541-549.

Research output: Contribution to journalArticle

Nargi-Aizenman, Jennifer L. ; Havert, Michael B. ; Zhang, Ming ; Irani, David N. ; Rothstein, Jeffrey D. ; Griffin, Diane E. / Glutamate Receptor Antagonists Protect from Virus-induced Neural Degeneration. In: Annals of Neurology. 2004 ; Vol. 55, No. 4. pp. 541-549.
@article{a742229e83924566a82879aa61f9f3c6,
title = "Glutamate Receptor Antagonists Protect from Virus-induced Neural Degeneration",
abstract = "Neuronal damage during acute viral encephalomyelitis can result directly from virus infection or indirectly from the host immune response to infection. In neurodegenerative diseases and stroke, neuronal death also can result from excess release of excitatory amino acid neurotransmitters, such as glutamate. To determine the role of glutamate excitotoxicity in fatal alphavirus-induced paralytic encephalomyelitis, we treated mice infected with neuroadapted Sindbis virus (NSV) with antagonists of N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) subtypes of glutamate receptors. Both apoptotic and necrotic neurons in the hippocampus were decreased in animals treated with MK-801, an NMDA receptor antagonist, or GYKI-52466, an AMPA receptor antagonist. However, only AMPA receptor blockade prevented damage to spinal cord motor neurons and protected mice from paralysis and death due to NSV infection. Protection was not caused by altered virus replication because treatment did not affect virus distribution and actually delayed virus clearance. These results provide evidence that NSV infection activates neurotoxic pathways that result in aberrant glutamate receptor stimulation and neuronal damage. Furthermore, AMPA receptor-mediated motor neuron death is an important contributor to paralysis and mortality in acute alphavirus-induced encephalomyelitis.",
author = "Nargi-Aizenman, {Jennifer L.} and Havert, {Michael B.} and Ming Zhang and Irani, {David N.} and Rothstein, {Jeffrey D.} and Griffin, {Diane E.}",
year = "2004",
month = "4",
doi = "10.1002/ana.20033",
language = "English (US)",
volume = "55",
pages = "541--549",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Glutamate Receptor Antagonists Protect from Virus-induced Neural Degeneration

AU - Nargi-Aizenman, Jennifer L.

AU - Havert, Michael B.

AU - Zhang, Ming

AU - Irani, David N.

AU - Rothstein, Jeffrey D.

AU - Griffin, Diane E.

PY - 2004/4

Y1 - 2004/4

N2 - Neuronal damage during acute viral encephalomyelitis can result directly from virus infection or indirectly from the host immune response to infection. In neurodegenerative diseases and stroke, neuronal death also can result from excess release of excitatory amino acid neurotransmitters, such as glutamate. To determine the role of glutamate excitotoxicity in fatal alphavirus-induced paralytic encephalomyelitis, we treated mice infected with neuroadapted Sindbis virus (NSV) with antagonists of N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) subtypes of glutamate receptors. Both apoptotic and necrotic neurons in the hippocampus were decreased in animals treated with MK-801, an NMDA receptor antagonist, or GYKI-52466, an AMPA receptor antagonist. However, only AMPA receptor blockade prevented damage to spinal cord motor neurons and protected mice from paralysis and death due to NSV infection. Protection was not caused by altered virus replication because treatment did not affect virus distribution and actually delayed virus clearance. These results provide evidence that NSV infection activates neurotoxic pathways that result in aberrant glutamate receptor stimulation and neuronal damage. Furthermore, AMPA receptor-mediated motor neuron death is an important contributor to paralysis and mortality in acute alphavirus-induced encephalomyelitis.

AB - Neuronal damage during acute viral encephalomyelitis can result directly from virus infection or indirectly from the host immune response to infection. In neurodegenerative diseases and stroke, neuronal death also can result from excess release of excitatory amino acid neurotransmitters, such as glutamate. To determine the role of glutamate excitotoxicity in fatal alphavirus-induced paralytic encephalomyelitis, we treated mice infected with neuroadapted Sindbis virus (NSV) with antagonists of N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) subtypes of glutamate receptors. Both apoptotic and necrotic neurons in the hippocampus were decreased in animals treated with MK-801, an NMDA receptor antagonist, or GYKI-52466, an AMPA receptor antagonist. However, only AMPA receptor blockade prevented damage to spinal cord motor neurons and protected mice from paralysis and death due to NSV infection. Protection was not caused by altered virus replication because treatment did not affect virus distribution and actually delayed virus clearance. These results provide evidence that NSV infection activates neurotoxic pathways that result in aberrant glutamate receptor stimulation and neuronal damage. Furthermore, AMPA receptor-mediated motor neuron death is an important contributor to paralysis and mortality in acute alphavirus-induced encephalomyelitis.

UR - http://www.scopus.com/inward/record.url?scp=1642305906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642305906&partnerID=8YFLogxK

U2 - 10.1002/ana.20033

DO - 10.1002/ana.20033

M3 - Article

C2 - 15048893

AN - SCOPUS:1642305906

VL - 55

SP - 541

EP - 549

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 4

ER -